Table 1. Patients at Potential Increased Risk of Hematogenous Total Joint Infection
A. Immunocompromised/immunosupressed patients
Inflammatory arthropathies: rheumatoid arthritis, systemic lupus erythematosus
Disease, drug or radiation-induced immunosuppression
B. Other Patients
Insulin-dependent (Type 1) diabetes
First two years following joint placement
Previous prosthetic joint infections
Malnourishment
Hemophilia
Table 2. Incidence Stratification of Bacteremic Dental Procedures*
HIGHER INCIDENCE1
Dental extractions
Periodontal procedures including surgery, subgingival placement of antibiotic fibers/strips, scaling and root planing, probing, recall maintenance
Dental implant placement and reimplantation of avulsed teeth
Endodontic (root canal) instrumentation or surgery only beyond the apex Initial placement of orthodontic bands but not brackets
Intraligamentary local anesthetic injections
Prophylactic cleaning of teeth or implants where bleeding is anticipated
LOWER INCIDENCE2
Restorative dentistry3 (operative and prosthodontic) with/without retraction cord4
Local anesthetic injections (nonintraligamentary)
Intracanal endodontic treatment; post-placement and buildup
Placement of rubber dam
Postoperative suture removal
Placement of removable prosthodontic/orthodontic appliances
Taking of oral impressions
Fluoride treatments
Taking of oral radiographs
Orthodontic appliance adjustment
Prophylaxis should be considered for patients with total joint replacement that meet the criteria in Table 1. No other patients with orthopaedic implants should be considered for antibiotic prophylaxis prior to dental treatment/procedures.
Prophylaxis not indicated.
This includes restoration of carious (decayed) or missing teeth.
Clinical judgment may indicate antibiotic use in selected circumstances that may create significant bleeding.
*Adapted from: Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association, from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young. Reprinted with permission of the Journal of the American Medical Association.22
Table 3. Suggested antibiotic prophylaxis regimens*
Patients not allergic to penicillin: cephalexin, cephradine or amoxicillin: 2 grams orally 1 hour prior to dental procedure.
Patients not allergic to penicillin and unable to take oral medications: cefazolin 1 gram or ampicillin 2 grams IM/IV 1 hour prior to the procedure.
Patients allergic to penicillin: clindamycin: 600 mg orally 1 hour prior to the dental procedure.
Patients allergic to penicillin and unable to take oral medications: clindamycin 600 mg IM/IV 1 hour prior to the procedure.
*No second doses are recommended for any of these dosing regimens.
REFERENCES
Pallasch TJ, Slots J: Antibiotic prophylaxis and the medically compromised patient. Periodontology 2000 1996;10:107-138
Rubin R, Salvati EA, Lewis R: Infected total hip replacement after dental procedures. Oral Surg. 1976;41:13-23.
Hansen AD, Osmon DR, Nelson CL: Prevention of deep prosthetic joint infection. J Bone Joint Surg 1996;78-A(3):458-471.
Bender IB, Naidorf IJ, Garvey GJ: Bacterial endocarditis: A consideration for physicians and dentists. J Amer Dent Assoc 1984;109:415-420.
Everett ED, Hirschmann JV: Transient bacteremia and endocarditis prophylaxis: A review. Medicine 1977; 56:61-77.
Guntheroth WG: How important are dental procedures as a cause of infective endocarditis? Amer J Cardiol 1984;54:797-801.
Jacobsen JJ, Schweitzer SO, DePorter DJ, Lee JJ: Antibiotic prophylaxis for dental patients with joint prostheses? A decision analysis. Int J Technol Assess Health Care 1990;6:569-587.
Tsevat J, Durand-Zaleski I, Pauker SG: Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. Amer J Pub Health 1989;79:739-743.
Norden CW: Prevention of bone and joint infections. Amer J Med 1985;78(Suppl 6B):229-232.
McGowan DA: Dentistry and endocarditis. Br Dent J 1990;169:69.
Bartzokas CA, Johnson R, Jane M, Martin MV, Pearce PK, Saw Y: Relation between mouth and haematogenous infections in total joint replacement. BMJ 1994;309:506-508.
Ching DW, Gould IM, Rennie JA, Gibson PH: Prevention of late haematogenous infection in major prosthetic joints. J Antimicrob Chemother 1989;23:676-680.
Council on Dental Therapeutics. Management of dental patients with prosthetic joints. J Amer Dent Assoc 1990;121:537-538.
Eskinazi D, Rathburn W: Is systematic antimicrobial prophylaxis justified in dental patients with prosthetic joints? Oral Surg Oral Med Oral Pathol 1988;66:430-431.
Cawson RA: Antibiotic prophylaxis for dental treatment: For hearts but not for prosthetic joints. Br Dent J 1992;304:933-934.
Brause BD: Infections associated with prosthetic joints. Clin Rheum Dis 1986;12:523-536.
Murray RP, Bourne WH, Fitzgerald RH: Metachronus infection in patients who have had more than one total joint arthroplasty. J Bone Joint Surg 1991;73-A:1469-1474.
Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB: Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop1984;182:117-126.
Jacobson JJ, Millard HD, Plezia R, Blankenship JR: Dental treatment and late prosthetic joint infections. Oral Surg Oral Med Oral Pathol 1986; 61:413-417.
Johnson DP, Bannister GG: The outcome of infected arthroplasty of the knee. J Bone Joint Surg 1986;688:289-291.
Jacobson JJ, Patel B, Asher G, Wooliscroft JO, Schaberg D: Oral Staphyloccus in elderly subjects with rheumatiod arthritis. J Amer Geriatr Soc 1997;45:1-5.
Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G: Prevention of bacterial endocarditis: Recommendations by the American Heart Association. From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young. JAMA 1997;277:1974-1801.
|
